BDO Wealth Advisors’s Anavex Life Sciences AVXL Stock Holding History

BDO Wealth Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-500	Closed	-$2K	–	616
2019 Q1	$2K	Buy	+500	New	+$1.19K	﹤0.01%	560
2018 Q4	–	Sell	-500	Closed	-$1K	–	548
2018 Q3	$1K	Hold	500	–	–	﹤0.01%	594
2018 Q2	$1K	Hold	500	–	–	﹤0.01%	613
2018 Q1	$1K	Buy	+500	New	+$1.41K	﹤0.01%	539

Other funds holding AVXL

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BDO Wealth Advisors's AVXL Position: Q2 2019 in Review

BDO Wealth Advisors sold out of Anavex Life Sciences (AVXL) in Q2 2019, closing a stake of 500 shares — an estimated $2K sold.

BDO Wealth Advisors first reported a position in AVXL in Q1 2018 and held it in 4 quarters. The position peaked at $2K in Q1 2019. 59 funds tracked by Wall St. Rank hold AVXL as of Q2 2019.

BDO Wealth Advisors reported no remaining Anavex Life Sciences position as of Q2 2019 after selling out during the quarter.
BDO Wealth Advisors sold 500 Anavex Life Sciences shares in Q2 2019, an estimated $2K.
BDO Wealth Advisors first reported a position in Anavex Life Sciences in Q1 2018 and held it in 4 quarters.
BDO Wealth Advisors's Anavex Life Sciences position peaked at $2K in Q1 2019.
59 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2019.

Based on BDO Wealth Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.